{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:01:44Z","timestamp":1787029304673,"version":"build-2736575974"},"reference-count":20,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:00:00Z","timestamp":1626739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacy"],"abstract":"<jats:p>Documented penicillin allergies have been associated with an increased risk of adverse outcomes. The goal of this project was to assess the effectiveness and feasibility of a pharmacist-led penicillin allergy \u201cde-labeling\u201d process that does not involve labor-intensive skin testing or direct oral challenges. Adult patients with penicillin allergies were identified and interviewed by an infectious diseases pharmacy resident during a 3-month pilot period. Using an evidence-based standardized checklist, the pharmacist determined if an allergy qualified for de-labeling. In total, 66 patients were interviewed during the pilot period. The average time spent was 5.2 min per patient interviewed. Twelve patients (18%) met the criteria for de-labeling and consented to the removal of the allergy. Four patients (6%) met the criteria but declined removal of the allergy. In brief, 58.3% of patients (7\/12) who were de-labeled and 50% of patients (2\/4) who declined de-labeling but had their allergy updated to reflect intolerance were subsequently prescribed beta-lactam antibiotics and all (9\/9, 100%) were able to tolerate these agents. A pharmacist-led penicillin allergy de-labeling process utilizing a standardized checklist is an effective and feasible method for removing penicillin allergies in patients without a true allergy.<\/jats:p>","DOI":"10.3390\/pharmacy9030127","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T11:26:10Z","timestamp":1626780370000},"page":"127","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Effectiveness and Feasibility of Pharmacist-Driven Penicillin Allergy De-Labeling Pilot Program without Skin Testing or Oral Challenges"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5622-9424","authenticated-orcid":false,"given":"You-Chan","family":"Song","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Abbott Northwestern Hospital, Mail Route 11321, 800 East 28th Street, Minneapolis, MN 55407, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2759-801X","authenticated-orcid":false,"given":"Zachary J.","family":"Nelson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Abbott Northwestern Hospital, Mail Route 11321, 800 East 28th Street, Minneapolis, MN 55407, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Wankum","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Abbott Northwestern Hospital, Mail Route 11321, 800 East 28th Street, Minneapolis, MN 55407, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista D.","family":"Gens","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Abbott Northwestern Hospital, Mail Route 11321, 800 East 28th Street, Minneapolis, MN 55407, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jama.2018.19283","article-title":"Evaluation and Management of Penicillin Allergy: A Review","volume":"321","author":"Shenoy","year":"2019","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/all.13168","article-title":"Clinical Outcomes Following Inpatient Penicillin Allergy Testing: A Systematic Review and Meta-Analysis","volume":"72","author":"Sacco","year":"2017","journal-title":"Allergy"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Blumenthal, K.G., Lu, N., Zhang, Y., Li, Y., Walensky, R.P., and Choi, H.K. (2018). Risk of Meticillin Resistant Staphylococcus Aureus and Clostridium Difficile in Patients with a Documented Penicillin Allergy: Population Based Matched Cohort Study. BMJ, 361.","DOI":"10.1136\/bmj.k2400"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/cid\/cix794","article-title":"The Impact of a Reported Penicillin Allergy on Surgical Site Infection Risk","volume":"66","author":"Blumenthal","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/jac\/dkz082","article-title":"Evaluation of a Pharmacist-Led Penicillin Allergy de-Labelling Ward Round: A Novel Antimicrobial Stewardship Intervention","volume":"74","author":"Devchand","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jpeds.2009.10.048","article-title":"Clindamycin-Resistant Group B Streptococcus and Failure of Intrapartum Prophylaxis to Prevent Early-Onset Disease","volume":"156","author":"Blaschke","year":"2010","journal-title":"J. Pediatr."},{"key":"ref_7","unstructured":"(2020, June 21). Prevention of Perinatal Group B Streptococcal Disease, Available online: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5910a1.htm."},{"key":"ref_8","unstructured":"(2020, June 21). Prevention of Group B Streptococcal Early-Onset Disease in Newborns|ACOG. Available online: https:\/\/www.acog.org\/clinical\/clinical-guidance\/committee-opinion\/articles\/2020\/02\/prevention-of-group-b-streptococcal-early-onset-disease-in-newborns."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jaip.2017.11.012","article-title":"Use of a Penicillin Allergy Screening Algorithm and Penicillin Skin Testing for Transitioning Hospitalized Patients to First-Line Antibiotic Therapy","volume":"6","author":"Ramsey","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.anai.2019.04.009","article-title":"Acute Care Beta-Lactam Allergy Pathways: Approaches and Outcomes","volume":"123","author":"Wolfson","year":"2019","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jaip.2017.08.006","article-title":"The Cost of Penicillin Allergy Evaluation","volume":"6","author":"Blumenthal","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_12","unstructured":"(2020, February 06). Evaluation and Diagnosis of Penicillin Allergy for Healthcare Professionals | Community | Antibiotic Use | CDC, Available online: https:\/\/www.cdc.gov\/antibiotic-use\/community\/for-hcp\/Penicillin-Allergy.html."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/ewjm.172.5.341","article-title":"Ten Percent of Patients Who Are Allergic to Penicillin Will Have Serious Reactions If Exposed to Cephalosporins","volume":"172","author":"Herbert","year":"2000","journal-title":"West. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra993637","article-title":"Cephalosporin Allergy","volume":"345","author":"Kelkar","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jemermed.2011.05.035","article-title":"The Use of Cephalosporins in Penicillin-Allergic Patients: A Literature Review","volume":"42","author":"Campagna","year":"2012","journal-title":"J. Emerg. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaip.2017.08.027","article-title":"Cross-Reactivity in \u03b2-Lactam Allergy","volume":"6","author":"Zagursky","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_17","unstructured":"(2010). Joint Task Force on Practice Parameters Drug Allergy: An Updated Practice Parameter. Ann. Allergy Asthma Immunol., 105, 78."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"AB175","DOI":"10.1016\/j.jaci.2019.12.367","article-title":"Association of Penicillin Allergy Documentation and Antibiotic Use: A National Inpatient Study","volume":"145","author":"Blumenthal","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_19","unstructured":"Mattingly II, T.J., and Heil, E.L. The Economics of Penicillin Allergy Testing: Still Scratching the Value Surface. Clin. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.jaip.2017.12.033","article-title":"The Cost of Self-Reported Penicillin Allergy: A Systematic Review","volume":"6","author":"Mattingly","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."}],"container-title":["Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2226-4787\/9\/3\/127\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:32:17Z","timestamp":1760164337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2226-4787\/9\/3\/127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,20]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["pharmacy9030127"],"URL":"https:\/\/doi.org\/10.3390\/pharmacy9030127","relation":{},"ISSN":["2226-4787"],"issn-type":[{"value":"2226-4787","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,20]]}}}